3-hydroxy-N6,N6,N6-trimethyl-L-lysine zwitterion

Metabolite details

Identifier

ZRJHLGYVUCPZNH-MQWKRIRWSA-O

InChI Key

ZRJHLGYVUCPZNH-MQWKRIRWSA-O

IUPAC name

(2S)-2-azaniumyl-3-hydroxy-6-(trimethylazaniumyl)hexanoate

Preferred name

3-hydroxy-N6,N6,N6-trimethyl-L-lysine zwitterion

INN name

—

Synonym

—

ChEBI

CHEBI:57515

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Transcriptional differentiation of Trypanosoma brucei during in vitro acquisition of resistance to acoziborole
• Metabolic Responses of a Model Green Microalga Euglena gracilis to Different Environmental Stresses
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• WT_vs_WT_Aco
• Control_vs_Paramycin
• Control_vs_Lithogenic_Diet
• Control_vs_OXPA_Treatment
• Control_vs_OXPA_Treatment
• G1_PBS_vs_G2_DSS